Press Releases

Bernstein Liebhard LLP reports on a February 15, 2012 article published in the New York Times revealing that Johnson & Johnson (“J&J”) continued to sell one model of its DePuy ASR hip replacement implants abroad after the U.S. Food and Drug Administration (“FDA”) rejected J&J’s...

PRESS RELEASE: Bernstein Liebhard LLP reports that on February 3, 2012, the U.S. Judicial Panel on Multidistrict Litigation (“JPML”) ordered that all Fosamax lawsuits filed in federal court by individuals alleging that they sustained an atypical femur fracture as a result of taking the bispho...

PRESS RELEASE: Bernstein Liebhard LLP reports that on February 7, 2012, the U.S. Judicial Panel on Multidistrict Litigation ordered that three separate pelvic mesh MDLs be consolidated before one judge given that each group of lawsuits, which involve various models of surgical mesh manufactured b...

PRESS RELEASE: Bernstein Liebhard LLP reports that on January 31, 2012, Democratic Representative Edward Markey of Massachusetts introduced a bill (HR3847) that would block medical devices from utilizing the 510(k) process in order to receive market approval by the U.S. Food and Drug Administrati...

PRESS RELEASE: Bernstein Liebhard LLP reports that on January 20, 2012, Representative Henry Waxman of California led House Democrats from the Energy and Commerce Committee in writing a letter to several chairmen, requesting that the Committee hold hearings to review the safety of medical devices...

PRESS RELEASE: On February 1, 2012, Bernstein Liebhard LLP reported that more than 900 federal DePuy Pinnacle hip replacement lawsuits  have been filed and have been included in the multidistrict litigation, In re: DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation (“M...

PRESS RELEASE: On January 30, 2012, Bernstein Liebhard LLP reported that health regulators in Britain are concerned that recipients of the metal-on-metal DePuy ASR hip implants were never notified that the devices were recalled.  In August 2010, DePuy Orthopaedics, a subsidiary of Johnson & ...

PRESS RELEASE: Bernstein Liebhard LLP reports that on December 8, 2011, the U.S. Food and Drug Administration (“FDA”) sent a warning letter to Johnson & Johnson subsidiary, DePuy Orthopaedics, to stop selling joint replacements that have not been properly approved by the FDA.  According...

PRESS RELEASE: Bernstein Liebhard LLP reports on a new study published in The New England Journal of Medicine, concluding that bone loss and osteoporosis develop so slowly that women who have normal bone density at age 65 can wait 15 years before undergoing a second bone density test.  As report...

PRESS RELEASE: Bernstein Liebhard LLP reports on a new law that would compel drug and medical device manufacturers to disclose any money paid to doctors for research, speaking, consulting, travel and entertainment.  According to a January 17, 2012 article published in the New York Times, under t...